Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in CattleBusiness Wire • 09/30/25
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial ResultsBusiness Wire • 09/23/25
Zoetis (ZTS) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 09/15/25
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA PainZacks Investment Research • 09/15/25
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in CatsBusiness Wire • 09/12/25
Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceBusiness Wire • 08/27/25
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/11/25